The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio is indicated for adult patients, aged 50 years and older, presenting at a specialized care setting with signs and symptoms of cognitive decline.
Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting
Frozen (preferred) - 1 month
Refrigerated - 1 day
Ambient - 3 hours
Fujirebio Lumipulse chemiluminescent enzyme immunoassay (CLEIA)
See report